Aurobindo, Hetero, and Vivimed Class Action Settlements in Maryland
Aurobindo, Hetero, and Vivimed class action settlements that covered Maryland residents — and where each one now stands.
Last checked: August 11, 2026 · By Class Action Buddy
Maryland residents have no confirmed open class action settlements involving Aurobindo, Hetero, and Vivimed right now. The Aurobindo, Hetero, and Vivimed settlement below has closed — the claim deadline has passed and no new claims can be filed. If you are looking for something you can still claim, our list of open settlements is checked against each administrator.
Class Action Buddy fills in official claim forms from your saved profile in under 60 seconds, then prints and posts the completed claim for you. There is nothing to file against Aurobindo, Hetero, and Vivimed at the moment — see what is open now.
Closed Aurobindo, Hetero, and Vivimed Settlements for Maryland Residents (1)
This Aurobindo, Hetero, and Vivimed settlement is no longer accepting claims. It closed on the date shown and the deadline cannot be reopened. It is listed here because the settlement and its administrator are a matter of record and people still search for it. For settlements that are open today, see our list of open settlements.
$15.2M Valsartan, Losartan and Irbesartan class action settlement
Up to TBDFile your claim for the $15.2M Valsartan, Losartan, and Irbesartan settlement. Blood pressure medication contaminated with cancer-causing substances.
About Aurobindo, Hetero, and Vivimed Class Actions in Maryland
Before you read on: the Aurobindo, Hetero, and Vivimed settlement described below has closed. This section explains what it was about and who was covered, which is still worth knowing — but it cannot be claimed now. See settlements that are open today.
Maryland residents affected by contaminated blood pressure medications from Aurobindo, Hetero, and Vivimed may be eligible for compensation through the $15.2 million valsartan, losartan, and irbesartan class action settlement. These Indian pharmaceutical manufacturers distributed contaminated generic medications throughout the United States, including Maryland's healthcare system. Maryland's Consumer Protection Act provides additional safeguards for residents, allowing for potential treble damages in cases of unfair or deceptive trade practices involving pharmaceuticals. The state's proximity to major East Coast distribution hubs means many Maryland pharmacies received these contaminated medications. Generic drug manufacturers like these three companies supply approximately 90% of prescriptions filled in Maryland through major pharmacy chains and independent pharmacies. Maryland residents filing class action claims must be aware that the state follows a three-year statute of limitations for personal injury claims, though discovery rules may extend this timeframe. The Maryland Attorney General's office has been active in pharmaceutical litigation, providing additional oversight for residents affected by contaminated medications distributed by these manufacturers.
Aurobindo, Hetero, and Vivimed Settlements in Maryland: FAQs
What makes Maryland residents eligible for the Aurobindo, Hetero, and Vivimed settlement?
Maryland residents who took valsartan, losartan, or irbesartan manufactured by these companies between 2012-2018 may qualify for the $15.2 million settlement. Eligibility requires proof of prescription fills from Maryland pharmacies that dispensed the contaminated medications. Medical documentation showing adverse effects or cancer diagnoses may increase compensation amounts.
How does Maryland's Consumer Protection Act affect claims against these pharmaceutical companies?
Maryland's Consumer Protection Act allows residents to seek additional damages beyond the class action settlement for deceptive trade practices. This state law provides stronger consumer protections than federal regulations alone. Maryland residents may pursue individual claims while participating in the class action settlement.
Are there specific deadlines for Maryland residents to file claims against Aurobindo, Hetero, and Vivimed?
Maryland follows a three-year statute of limitations for personal injury claims, but the discovery rule may extend this deadline for contaminated medication cases. The class action settlement has specific filing deadlines that override state statutes. Maryland residents should file claims promptly to preserve all legal options under both state and federal law.
Tips for Maryland Residents Filing Aurobindo, Hetero, and Vivimed Claims
Maryland residents should gather prescription records from all pharmacies where they filled valsartan, losartan, or irbesartan prescriptions between 2012-2018. Contact your pharmacy to identify the manufacturer of your specific generic medication, as multiple companies produced these drugs. Keep detailed medical records documenting any adverse health effects or cancer diagnoses following use of these medications. Consider consulting with Maryland attorneys experienced in pharmaceutical litigation, as state consumer protection laws may provide additional compensation beyond the class action settlement. File claims before deadlines expire and maintain copies of all documentation submitted.
File Aurobindo, Hetero, and Vivimed Claims in 60 Seconds
Class Action Buddy auto-fills your claim forms and submits them electronically. Your first claim is free.
